Open access
Jan 2026
Identification of a Novel Subtype‐Derived Prognostic Signature Based on Nucleotide Metabolism‐Related Molecular Classification for Predicting Lung Adenocarcinoma Prognosis
Background Lung adenocarcinoma (LUAD) is a major subtype of nonsmall cell lung cancer with substantial clinical heterogeneity. Nucleotide metabolism‐related genes may contribute to tumor progression and immune microenvironment remodeling, but their prognostic value in LUAD remains incompletely defined. Methods Bulk tra...
Yue Shi, Shan-Shan Li, Lin Zhao et al.
· International Journal of Gen... · 0 citations